geoopen
In Vivo efficacy assessment of the CDK4/6 inhibitor palbociclib and the PLK1 inhibitor volasertib in Human Chordoma Xenografts [Target-seq]
GEO Series GSE216417. Homo sapiens. 6 samples. Type: Genome variation profiling by high throughput sequencing.
ShareScore
20/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 4
- Harmonization
- 8
- Access
- 0
- Reuse readiness
- 0
- Engagement
- 8